- Nicolas Janvier analyzed market opportunities in small-cap stocks as the Russell 2000 index achieved another record high.
- The index surge occurred while the Dow and S&P 500 posted losses during trading.
- Janvier highlighted top stock picks including Lam Research, United Rentals, and Eli Lilly.
- Investors often focus narrowly on prominent AI infrastructure giants while overlooking companies applying artificial intelligence to fields like biopharmaceuticals.
- Biopharmaceutical firms are increasingly utilizing artificial intelligence platforms to accelerate drug discovery, highlighted by successful clinical trials such as Insilico Medicine's Rentosertib and major industry partnerships involving Eli Lilly and Nvidia.
- Experts argue that the greatest investment opportunities lie in companies leveraging artificial intelligence to create revolutionary commercial innovations rather than merely building the underlying technology.